CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Khellin 100mg  | ≥95%

CSNpharm

Khellin, a naturally occurring furochromone, is an EGFR inhibitor with an IC50 of 0.15 µM. Khelline has anti-proliferative activity in vitro. Khellin has antispasmodic and coronary vasodilator effects[1][2].

More Information Supplier Page

KHK-IN-1 HCl 50mg  | ≥98%

CSNpharm

KHK-IN-1 HCl is a potent ketohexokinase (KHK) inhibitor with IC50 of 12 nM, interacts with Asp-27B in the ATP-binding region of KHK.

More Information Supplier Page

KHK-IN-1 HCl 1mg  | ≥98%

CSNpharm

KHK-IN-1 HCl is a potent ketohexokinase (KHK) inhibitor with IC50 of 12 nM, interacts with Asp-27B in the ATP-binding region of KHK.

More Information Supplier Page

KHK-IN-1 HCl 5mg  | ≥98%

CSNpharm

KHK-IN-1 HCl is a potent ketohexokinase (KHK) inhibitor with IC50 of 12 nM, interacts with Asp-27B in the ATP-binding region of KHK.

More Information Supplier Page

KHK-IN-1 HCl 10mg  | ≥98%

CSNpharm

KHK-IN-1 HCl is a potent ketohexokinase (KHK) inhibitor with IC50 of 12 nM, interacts with Asp-27B in the ATP-binding region of KHK.

More Information Supplier Page

KHK-IN-1 HCl 25mg  | ≥98%

CSNpharm

KHK-IN-1 HCl is a potent ketohexokinase (KHK) inhibitor with IC50 of 12 nM, interacts with Asp-27B in the ATP-binding region of KHK.

More Information Supplier Page

KN-92 HCl 50mg  | ≥98%

CSNpharm

KN-92 HCl a selective inhibitor of Ca2+/calmodulin-dependent kinase II (CaMKII), competitively blocking CaM binding to the kinase (Ki = 370 nM).

More Information Supplier Page

KN-92 HCl 1mg  | ≥98%

CSNpharm

KN-92 HCl a selective inhibitor of Ca2+/calmodulin-dependent kinase II (CaMKII), competitively blocking CaM binding to the kinase (Ki = 370 nM).

More Information Supplier Page

KN-92 HCl 5mg  | ≥98%

CSNpharm

KN-92 HCl a selective inhibitor of Ca2+/calmodulin-dependent kinase II (CaMKII), competitively blocking CaM binding to the kinase (Ki = 370 nM).

More Information Supplier Page

KN-92 HCl 10mg  | ≥98%

CSNpharm

KN-92 HCl a selective inhibitor of Ca2+/calmodulin-dependent kinase II (CaMKII), competitively blocking CaM binding to the kinase (Ki = 370 nM).

More Information Supplier Page

KN-92 HCl 25mg  | ≥98%

CSNpharm

KN-92 HCl a selective inhibitor of Ca2+/calmodulin-dependent kinase II (CaMKII), competitively blocking CaM binding to the kinase (Ki = 370 nM).

More Information Supplier Page

KN-93 5mg  | ≥99%

CSNpharm

KN-93 is a potent Ca2+/calmodulin-dependent protein kinase II (CaMKII) selective inhibitor with Ki of 370 nM.

More Information Supplier Page

KN-93 25mg  | ≥99%

CSNpharm

KN-93 is a potent Ca2+/calmodulin-dependent protein kinase II (CaMKII) selective inhibitor with Ki of 370 nM.

More Information Supplier Page

KN-93 50mg  | ≥99%

CSNpharm

KN-93 is a potent Ca2+/calmodulin-dependent protein kinase II (CaMKII) selective inhibitor with Ki of 370 nM.

More Information Supplier Page

KN-93 10mg  | ≥99%

CSNpharm

KN-93 is a potent Ca2+/calmodulin-dependent protein kinase II (CaMKII) selective inhibitor with Ki of 370 nM.

More Information Supplier Page

KN-93 1mg  | ≥99%

CSNpharm

KN-93 is a potent Ca2+/calmodulin-dependent protein kinase II (CaMKII) selective inhibitor with Ki of 370 nM.

More Information Supplier Page

KNK437 10mg  | ≥99%

CSNpharm

KNK437 is a pan-HSP inhibitor, which inhibits the synthesis of inducible HSPs, including HSP105, HSP72, and HSP40.

More Information Supplier Page

KNK437 100mg  | ≥99%

CSNpharm

KNK437 is a pan-HSP inhibitor, which inhibits the synthesis of inducible HSPs, including HSP105, HSP72, and HSP40.

More Information Supplier Page

KNK437 250mg  | ≥99%

CSNpharm

KNK437 is a pan-HSP inhibitor, which inhibits the synthesis of inducible HSPs, including HSP105, HSP72, and HSP40.

More Information Supplier Page

KNK437 1mg  | ≥99%

CSNpharm

KNK437 is a pan-HSP inhibitor, which inhibits the synthesis of inducible HSPs, including HSP105, HSP72, and HSP40.

More Information Supplier Page

KNK437 5mg  | ≥99%

CSNpharm

KNK437 is a pan-HSP inhibitor, which inhibits the synthesis of inducible HSPs, including HSP105, HSP72, and HSP40.

More Information Supplier Page

KNK437 50mg  | ≥99%

CSNpharm

KNK437 is a pan-HSP inhibitor, which inhibits the synthesis of inducible HSPs, including HSP105, HSP72, and HSP40.

More Information Supplier Page

KNK437 25mg  | ≥99%

CSNpharm

KNK437 is a pan-HSP inhibitor, which inhibits the synthesis of inducible HSPs, including HSP105, HSP72, and HSP40.

More Information Supplier Page

Koumine 1mg  | ≥99%

CSNpharm

Koumine is an indole alkaloid isolated from Gelsemium elegans Benth., possessing analgesic, anti-inflammatory and neurosteroid modulating activities.

More Information Supplier Page

Koumine 5mg  | ≥99%

CSNpharm

Koumine is an indole alkaloid isolated from Gelsemium elegans Benth., possessing analgesic, anti-inflammatory and neurosteroid modulating activities.

More Information Supplier Page

KS176 100mg  | ≥99%

CSNpharm

KS176 is a potent and selective inhibitor for the breast cancer resistance protein (BCRP) multidrug transporter with IC50s of 0.59 and 1.39 μM in Pheo A and Hoechst 33342 assays respectively.

More Information Supplier Page

KS176 10mg  | ≥99%

CSNpharm

KS176 is a potent and selective inhibitor for the breast cancer resistance protein (BCRP) multidrug transporter with IC50s of 0.59 and 1.39 μM in Pheo A and Hoechst 33342 assays respectively.

More Information Supplier Page

KS176 50mg  | ≥99%

CSNpharm

KS176 is a potent and selective inhibitor for the breast cancer resistance protein (BCRP) multidrug transporter with IC50s of 0.59 and 1.39 μM in Pheo A and Hoechst 33342 assays respectively.

More Information Supplier Page

KS176 1mg  | ≥99%

CSNpharm

KS176 is a potent and selective inhibitor for the breast cancer resistance protein (BCRP) multidrug transporter with IC50s of 0.59 and 1.39 μM in Pheo A and Hoechst 33342 assays respectively.

More Information Supplier Page

KS176 5mg  | ≥99%

CSNpharm

KS176 is a potent and selective inhibitor for the breast cancer resistance protein (BCRP) multidrug transporter with IC50s of 0.59 and 1.39 μM in Pheo A and Hoechst 33342 assays respectively.

More Information Supplier Page

KS176 25mg  | ≥99%

CSNpharm

KS176 is a potent and selective inhibitor for the breast cancer resistance protein (BCRP) multidrug transporter with IC50s of 0.59 and 1.39 μM in Pheo A and Hoechst 33342 assays respectively.

More Information Supplier Page

Kumatakenin 5mg  | ≥98%

CSNpharm

Kumatakenin, a natural product isolated and purified from the roots of Astragalus membranaceus, has antibacterial and antifungal activities.

More Information Supplier Page

Kumatakenin 1mg  | ≥98%

CSNpharm

Kumatakenin, a natural product isolated and purified from the roots of Astragalus membranaceus, has antibacterial and antifungal activities.

More Information Supplier Page

Kuromanine 1mg  | ≥98%

CSNpharm

Kuromanin, a natural product isolated and purified from the herbs of Chrysanthemum indicum, has been shown to improve blood glucose concentrations and lipid homeostasis and to reduce obesity.

More Information Supplier Page

Kuromanine 10mg  | ≥98%

CSNpharm

Kuromanin, a natural product isolated and purified from the herbs of Chrysanthemum indicum, has been shown to improve blood glucose concentrations and lipid homeostasis and to reduce obesity.

More Information Supplier Page